Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Change in Cash: 2023-2025

Historic Change in Cash for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to $2.7 million.

  • Immunocore Holdings' Change in Cash fell 87.01% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$54.4 million, marking a year-over-year decrease of 176.11%. This contributed to the annual value of $14.8 million for FY2024, which is 53.51% down from last year.
  • Latest data reveals that Immunocore Holdings reported Change in Cash of $2.7 million as of Q3 2025, which was up 441.28% from -$780,000 recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Change in Cash ranged from a high of $391.0 million in Q1 2024 and a low of -$327.7 million during Q2 2024.
  • In the last 3 years, Immunocore Holdings' Change in Cash had a median value of $10.2 million in 2023 and averaged $5.6 million.
  • Over the last 5 years, Immunocore Holdings' Change in Cash had its largest YoY gain of 2,758.78% in 2024, and its largest YoY loss of 3,304.04% in 2024.
  • Quarterly analysis of 3 years shows Immunocore Holdings' Change in Cash stood at -$12.3 million in 2023, then crashed by 461.17% to -$69.0 million in 2024, then slumped by 87.01% to $2.7 million in 2025.
  • Its Change in Cash stands at $2.7 million for Q3 2025, versus -$780,000 for Q2 2025 and $12.7 million for Q1 2025.